Latest news
BioCryst Bets On Rare Genetic Disorder Therapy Expansion Amid Q2 Earnings Beat – Retail Piles On Buyout Speculation - StocktwitsStocktwits · Fri, 07 Aug 2026 07:46:45 GMTEli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’ - StocktwitsStocktwits · Thu, 06 Aug 2026 21:30:50 GMTFUBO CEO Teases November Strategy Reveal After Strong North America Subscriber Growth In Q3 - StocktwitsStocktwits · Wed, 05 Aug 2026 13:29:35 GMTWULF CEO Says TeraWulf Is Moving To ‘Scaled’ Execution’ With Power Defining The AI Race Amid Earnings Miss - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:19:19 GMT